Investors
DISCLOSURE
Audited Financial Results of Subsidiary - Mangalam Laboratories Private Limited for the year ended 31st March, 2024
Code of Conduct for determining and monitoring trade by Designated Persons and Immediate relatives
Code of Conduct for Directors and SMP
Code of Fair Disclosure
Familiarization Programme
Leak of UPSI
Nomination-remuneration-policy
Policy for Determining Material Subsidiary
Policy on Board Diversity
Policy on criteria for determining the materiality of events
Policy on Preservation of Docs
Policy on Related Party Transaction
Stationary Monitoring Policy
Terms and Conditions for appointment of ID
Terms of Reference of all Committees
Terms of Reference of all Committees
Whistle Blower Policy
Annual Report 2017
Annual Report 2018
Annual Report 2019
Annual Report 2020
Annual Report 2021
Annual Return 2020
Annual Return 2021
Code of conduct of Board of Directors and Senior Management Personnel
Composition of various committees of Board of Directors
Financial Results as on 31.03.2018
Financial Results as on 31.03.2019
Financial Results as on 31.03.2020
Financial Results as on 31.03.2021
Financial Results as on 31.03.2022
Notice of Board meeting 09.05.2019
Notice of Board meeting 20.5.2021
Notice of Board meeting 26.5.2022
Notice of Board meeting 29.06.2020
Policy for determination of materiality of events or information
Policy on dealing with related party transactions
Shareholding Pattern as on 31.03.2018
Shareholding Pattern as on 31.03.2019
Shareholding Pattern as on 31.03.2020
Shareholding Pattern as on 31.03.2021
Shareholding Pattern as on 31.03.2022
Vigil mechanism- Whistle Blower policy
Un-Audited Financial Results for the quarter ended 30th September, 2024
Un-Audited Financial Results for the quarter ended 30th June, 2024
Audited Financial Results for the quarter and year ended 31st March, 2024
Un- Audited Financial Results for the quarter ended 31st December, 2023.
Un- Audited Financial Results for the quarter ended 30th September, 2023.
Un- Audited Financial Results for the quarter ended 30th June, 2023.
Audited Financial Results for the quarter and year ended 31st March, 2023
Unaudited Financial Results for the quarter ended 31st December, 2022
Unaudited Financial Results for the quarter ended 30th September, 2022
Unaudited Financial Results for the quarter ended 30th June, 2022
Audited Financial Results for the year ended 31st March 2022
Unaudited Financial Results for the quarter ended 31st December 2021
Unaudited Financial Results for the half year ended 30th September 2021
Unaudited Financial Results for the quarter ended 30th June 2021
Audited Financial Results for the year ended 31st March 2021
Unaudited Financial Results for the quarter ended 31st December 2020
Unaudited Financial Results for the half year ended 30th September 2020
Unaudited Financial Results for the quarter ended 30th June 2020
Audited Financial Results for the year ended 31st March 2020
Unaudited Financial Results for the quarter ended 31st December 2019
Unaudited Financial Results for the half year ended 30th September 2019
Unaudited Financial Results for the quarter ended 30th June 2019
Audited Financial Results for the year ended 31st March 2019
Unaudited Financial Results for the quarter ended 31st December 2018
Unaudited Financial Results for the half year ended 30th September 2018
Unaudited Financial Results for the quarter ended 30th June 2018
Audited Financial Results for the year ended 31st March 2018
Unaudited Financial Results for the quarter ended 31st December 2017
Unaudited Financial Results for the half year ended 30th September 2017
Unaudited Financial Results for the quarter ended 30th June 2017
Audited Financial Results for the year ended 31st March 2017
Unaudited Financial Results for the quarter ended 31st December 2016
Unaudited Financial Results for the half year ended 30th September 2016
Unaudited Financial Results for the quarter ended 30th June 2016
Audited Financial Results for the year ended 31st March 2016
Unaudited Financial Results for the quarter ended 31st December 2015
Unaudited Financial Results for the half year ended 30th September 2015
Unaudited Financial Results for the quarter ended 30th June 2015
Archival Policy
Code of Conduct for Directors
Code of Conduct Insider trading
Code of Fair Disclosure
Familarization Programme
Leak of UPSI
Nomination & Remuneration Policy
Policy for Determining Material Subsidiary
Policy on Board Diversity
Policy on Criteria for Determining Materiality of Events
Policy on Preservation of Docs
Policy on Related Party Transaction
Risk Management Policy
Stationary Monitoring Policy
Terms and Conditions for appointment of ID
Terms of Reference of all Committees
Whistle Blower Policy
Code of Conduct for determining and monitoring trade by Designated Persons and Immediate relatives
Code of Conduct for Directors and SMP
Code of Fair Disclosure
Familiarization Programme
Leak of UPSI
Nomination-remuneration-policy
Policy for Determining Material Subsidiary
Policy on Board Diversity
Policy on criteria for determining the materiality of events
Policy on Preservation of Docs
Policy on Related Party Transaction
Stationary Monitoring Policy
Terms and Conditions for appointment of ID
Terms of Reference of all Committees
Terms of Reference of all Committees
Whistle Blower Policy
Archival Policy
Determination of Materiality of any Event / Information
Code Of Conduct For Prohibition Of Insider Trading
Code Of Conduct
Nomination Of Remuneration Policy
Risk Management Policy
Policy On Related Party Transactions
Whistle Blower Policy
Shareholding pattern as 30.09.2024
Shareholding pattern as 30.06.2024
Shareholding pattern as on 31.03.2024
Shareholding pattern as on 31.12.2023
Shareholding pattern as on 30.09.2023
Shareholding pattern as 30.06.2023
Shareholding pattern as 31.03.2023
Shareholding pattern as 31.12.2022
Shareholding pattern as 30.09.2022
Shareholding pattern as 30.06.2022
Share holding Pattern as on 31.03.2022
Share holding Pattern as on 31.12.2021
Share holding Pattern as on 30.09.2021
Share holding Pattern as on 30.06.2021
Share holding Pattern as on 31.03.2021
Share holding Pattern as on 30.06.2020
Share holding Pattern as on 31.03.2020
Share holding Pattern as on 31.12.2019
Share holding Pattern as on 30.09.2019
Share holding Pattern as on 30.06.2019
Share holding Pattern as on 31.03.2019
Share holding Pattern as on 31.12.2018
Share holding Pattern as on 30.09.2018
Share holding Pattern as on 30.06.2018
Share holding Pattern as on 31.03.2018
Share holding Pattern as on 31.12.2017
Share holding Pattern as on 30.09.2017
Share holding Pattern as on 30.06.2017
Share holding Pattern as on 31.03.2017
Share holding Pattern as on 31.12.2016
Share holding Pattern as on 30.09.2016
Share holding Pattern as on 30.06.2016
Share holding Pattern as on 31.03.2016
Share holding Pattern as on 31.12.2015
Share holding Pattern as on 30.09.2015
Share holding Pattern as on 30.06.2015
Share holding Pattern as on 31.03.2015
Outcome of Board Meeting 14.11.2024
Intimation of Board Meeting to be held on 14.11.2024
Certificate Under regulation 76 of SEBI LODR Regulations, 2015
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Corporate Governance Report for the quarter ended 30th September, 2024
Intimation as per Regulation 30 of SEBI (LODR) Regulations, 2015 for participation in CPhI event
Intimation for Closure of Trading Window for the quarter ended September 30, 2024.
Voting Results of 51st AGM and Scrutinizers Report
Form MGT-7_31-03-2024
Intimation as per Regulation 30 of SEBI (LODR) Regulations, 2015 for expansion of API portfolio.
Update on grant received by Medicines for Malaria Venture ('MMV') for Research and Development purposes.
Newspaper Advertisement under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Outcome of Board meeting 13.08.2024
Intimation of Board Meeting to be held on 13.08.2024.
Certificate Under regulation 76 of SEBI LODR Regulations, 2015
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Corporate Governance Report for the quarter ended 30th June, 2024
Intimation for Closure of Trading Window for the quarter ended 30.06.2024
Outcome of Board meeting 18.06.2024
Newspaper Advertisement under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Outcome of Board meeting 21.05.2024
Intimation of Board Meeting to be held on 21.05.2024.
Certificate Under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Corporate Governance Report for the quarter ended 31st March, 2024
Certificate Under regulation 76 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Compliance Certificate Under regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Closure of Trading Window for the year ended March 31, 2024.
Outcome of Board meeting 15.03.2024
Intimation of Board Meeting to be held on 15.03.2024.
Newspaper Advertisement under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Outcome of Board meeting 13.02.2024
Intimation of Board Meeting to be held on 13.02.2024
Certificate Under regulation 76 of SEBI LODR Regulations, 2015
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Corporate Governance Report for the quarter ended 31st December, 2023
Intimation for Closure of Trading Window for the quarter ended December 31, 2023.
Newspaper Advertisement under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Outcome of Board meeting 08.11.2023
Intimation of Board Meeting to be hold on 08.11.2023
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Corporate Governance Report for the quarter ended 30th September, 2023
Certificate Under regulation 76 of SEBI LODR Regulations, 2015
Intimation for Closure of Trading Window for the quarter ended September 30, 2023
Voting Results of 50th AGM
Form MGT - 7
Independent Directors Familarisation Programme 2022-23
Independent Directors Familarization Programme 2022-23.
Newspaper Advertisement under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Outcome of Board meeting 10.08.2023
Intimation of Board Meeting to be hold on 10.08.2023
Certificate Under regulation 76 of SEBI LODR Regulations, 2015
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Corporate Governance Report for the quarter ended 30th June, 2023
Intimation for Closure of Trading Window for the quarter ended June 30, 2023.
Outcome of Board meeting 30.05.2023
Intimation of Board Meeting to be hold on 30.05.2023
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Voting Results of Postal Ballot
Scrutinizer’s Report
Certificate Under regulation 76 of SEBI LODR Regulations, 2015
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Corporate Governance Report for the quarter ended 31st March, 2023
Compliance Certificate - Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Certificate under Regulation 40 (9) 31.03.2023
Intimation for Closure of Trading Window for the year ended March 31, 2023
Notice of Postal Ballot
Newspaper Advertisement under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Outcome of Board Meeting 13.02.2023
Authorised Key Managerial Personnel under Regulation 30(5)
Criteria for making payment to Non- Executive Director
Outcome of Board Meeting 13.02.2023
Certificate Under regulation 76 of SEBI LODR Regulations, 2015
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Corporate Governance Report for the quarter ended 31st December, 2022
Intimation of Board Meeting 13.02.2023
Intimation for Closure of Trading Window for the quarter ended December 31, 2022
Outcome of Board Meeting 11.11.2022
Intimation of Board Meeting 11.11.2022
Intimation for Closure of Trading Window for the quarter ended September 30, 2022
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Corporate Governance Report for the quarter ended 30th September, 2022
Certificate under regulation 13(3) of SEBI LODR Regulations, 2015
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Independent Directors Familarisation Programme 2021-22
Form MGT-7
Outcome of Board meeting 05.08.2022
Intimation of Board Meeting 05.08.2022
Intimation of Closure Trading Windows
Postal Ballot
Out Come of Board Meeting 04.02.2022
Declaration with respect to Non - Applicability of Large Corporate Framework
Composition of Committee
Out Come of Board Meeting 26.05.2022
Intimation Board Meeting
Intimation of Result of postal Ballot and Scrutinizers Report
Intimation SAT Order
Intimation of Board Meeting 04.02.2022
Newspaper Advertisement under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Intimation regarding closure of Trading Window
Compliance Certificate - Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of Board Meeting dated 12th November, 2021.
Notice of Board Meeting to be held on 12.11.2021
Intimation for Closure of Trading Window for the quarter ended September 30, 2021
Intimation under Regulation 30
Voting Results of 48th AGM
Notice of 48th AGM
Intimation under Regulation 30 TTA
Outcome of Board Meeting dated 12th August, 2021
Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015
Notice of Board Meeting to be held on 12.08.2021
Outcome of Board Meeting dated 05th July, 2021
Outcome of Board Meeting dated 06th July, 2021
Intimation for Closure of Trading Window for the quarter ended June 30, 2021
Update on Setting-up of new intermediate manufacturing facility
Disclosure of RPT for the year ended March 31, 2021
Intimation regarding receipt of Resignation from Statutory Auditors
Notice of Board Meeting to be held on 20.05.2021
Intimation for Closure of Trading Window for the year ended March 31, 2021
Outcome of Board Meeting dated 21th March, 2021
Notice of 47th AGM
Newspaper Advertisement for attention of shareholders
Outcome of Board Meeting dated 10th August, 2020
Notice of Board Meeting to be held on 10.08.2020
Disclosure of RPT for the year ended March 31, 2020
Intimation for Closure of Trading Window for the quarter ended June 30, 2020
Outcome of Board Meeting dated 29th June, 2020
Notice of Board Meeting to be held on 29.06.2020
Update on Development of Favipiravir
Update on Certificate of Suitability (CEP) for Hydroxychloroquine Sulphate (HCQS)
Intimation for Closure of Trading Window for the quarter ended December 31, 2019
Notice of Board Meeting to be held on 24.01.2020
Update on Active Pharmaceutical Ingredients (APIs)
Intimation for Closure of Trading Window for the quarter ended March 31, 2020
Outcome of Board Meeting dated 24th January, 2020
Outcome of Board Meeting dated 2nd November 2019
Disclosure of RPT for the half year ended September 30 ,2019
Outcome of Board Meeting dated 2nd November, 2019
Notice of Board Meeting dated 02.11.2019
Intimation for Closure of Trading Window for the quarter ended September 30, 2019
Voting Results of 46th AGM
Disclosure of RPT for the FY ended 31st March ,2019
Intimation for closure of Trading Window for the quarter ended 30th June, 2019
Notice of 46th AGM
Attendance Slip of 46th AGM
Proxy Form of 46th AGM
Outcome of Board Meeting dated 26th July, 2019
Announcement under Regulation 30 (LODR)-Change in Directorate
Authorised Key Managerial Personnel under Regulation 30(5)
Notice of Board Meeting dated 26.07.2019
Outcome of Board Meeting dated 08th july, 2019
Outcome of Board Meeting dated 09.05.2019
Notice of Board Meeting dated 09.05.2019
Outcome of Board Meeting dated 11.02.2019
Notice of Board Meeting dated 11.02.2019
Outcome of Board Meeting dated 14.11.2018
Notice of Board Meeting dated 14.11.2018
Disclosure of Voting Results of 45th AGM of members of the Company held on 25.09.2018
Notice of 45th AGM
Proxy AGM 45th
Attendance Slip 45th AGM
Outcome of Board Meeting dated 14.08.2018
Reg 30 Updates Changes in Directorate
Notice of Board Meeting dated 14.08.2018
Notice of Board Meeting dated 28.05.2018
Outcome of Board Meeting dated 12.02.2018
Revised Outcome of Board Meeting dated 12.12.2017
Outcome of Board Meeting dated 12.12.2017
Outcome of Board Meeting dated 20.11.2017
Outcome of Board Meeting dated 11.08.2017
Outcome of Board Meeting dated 08.05.2017
Notice of Board Meeting dated 12.02.2018
Regulation 30 - Updates Change in Directors
Notice of Board Meeting dated 20.11.2017
Disclosure of Voting Results of 44th AGM of members of the Company held on 26.09.2017
Notice of Postponement of Board Meeting dated 04.08.2017
Notice of Board Meeting dated 04.08.2017
Authorized KMP
Regulation 30- Updates WHO Geneva Approval for Unit 2
Notice of Board Meeting dated 08.05.2017
Regulation 30- Updates WHO Geneva inspection at Unit 2
Notice of Board Meeting dated 06.02.2017
Regulation 30 Credit Rating Updates
Notice of Board Meeting dated 10.11.2016
Disclosure of Voting Results of 43rd AGM of members of the Company held on 30.09.2016
Proceedings of 43rd AGM
Notice of Board Meeting dated 01.08.2016
Notice of Postponement of Board Meeting dated 06.06.2016
Investor Presentation
Resignation Letter of Ms. Meenal Sukhani
Intimation under Regulation 30 of SEBI for change in directorship
Notice of Board Meeting dated 16.05.2016
Mangalam Drugs Organics Investor Presentation - Jan 2016
Rating Letter (Basel II)
Notice of Board Meeting 2016
Scrutinizers Report 2015
Scrutinizer Report for AGM held on 29th September 2014
Annual Report 2008
Annual Report 2009
Annual Report 2010
Annual Report 2011
Annual Report 2012
Annual Report 2013
Annual Report 2014
Annual Report 2015
Annual Report 2016
Annual Report 2017
Annual Report 2018
Annual Report 2019
Annual Report 2020
Annual Report 2021
Annual Report 2021-22
Annual Report 2022-23
Annual Report 2023-24
ANNUAL SECRETARIAL COMPLIANCE REPORT (24A)
Annual Secretarial Compliance Report MDOL with Covering letter
Secretarial Compliance Report 2020-21
Secretarial Compliance Report 15-06-2020
Details of Nodal Officer – IEPF
Shri Govardhan M. Dhoot – Chairman & Managing Director
Company Name: Mangalam Drugs & Organics Ltd.
CIN: L24230MH1972PLC116413
Registered Office:
Rupam Building, 3rd Floor, 239, P D’ Mello Road (Near GPO),
Mumbai – 400 001, Maharashtra, INDIA.
Tel: +91 – 22 – 2261 6200 / 6300>
Email ID: cs@mangalamdrugs.com
Unclaimed Dividend 2017-18 Interim Dividend
CIN: L24230MH1972PLC116413
Registered Office:
Rupam Building, 3rd Floor, 239, P D’ Mello Road (Near GPO),
Mumbai – 400 001, Maharashtra, INDIA.
Tel: +91 – 22 – 2261 6200 / 6300>
Email ID: cs@mangalamdrugs.com
Unclaimed Dividend 2017-18 Interim Dividend
Secretarial Department
Ms. Anuradha Pandey – Company Secretary & Compliance Officer
Mangalam Drugs & Organics Ltd.
Rupam Building, 3rd Floor,
239, P D’ Mello Road (Near GPO),
Mumbai – 400 001. Maharashtra, INDIA.
Tel: +91 – 22 – 2261 6200 / 6300
Email ID: cs@mangalamdrugs.com
R & T Agent
Link Intime India Pvt. Ltd.
C-101, 247 Park, L.B.S Marg,
Vikhroli (West), Mumbai-400083.
Tel No.: 91-22-49182670
Fax: 91 22 49186060
Email ID: cs@mangalamdrugs.com
Link Intime India Pvt. Ltd.
C-101, 247 Park, L.B.S Marg,
Vikhroli (West), Mumbai-400083.
Tel No.: 91-22-49182670
Fax: 91 22 49186060
Email ID: cs@mangalamdrugs.com
Grievance redressal and other relevant details:
Ms. Anuradha Pandey – Company Secretary & Compliance Officer
Mangalam Drugs & Organics Ltd.
Rupam Building, 3rd Floor,
239, P D’ Mello Road (Near GPO),
Mumbai – 400 001. Maharashtra, INDIA.
Tel: +91–22–2261 6200/6300
Email ID: cs@mangalamdrugs.com
